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Vascular Surgical Complications of the Acquired
Immunodeficiency Syndrome
J. D. Woolgar and J. V. Robbs
Durban Metropolitan Vascular Service, University of Natal, Durban, South Africa
The past twenty years has seen an explosive rise in the number of individuals infected with the Human Immunodeficiency
Virus (HIV). In sub-Saharan Africa, the Acquired Immunodeficiency Syndrome (AIDS) is the leading cause of death
among young adults with little sign of abating.
Immunosuppression and opportunistic infections associated with HIV infection have been responsible for various unusual
and unique surgical syndromes that have only recently been described. This review examines the vascular surgical
complications of the disease with particular regard to HIV-associated vasculitides, aneurysms and occlusive disease and
the implications for management.
Key Words: HIV; AIDS; Surgery and complications.
Introduction
Two decades have passed since the onset of the global
AIDS epidemic with no end in sight to what amounts
to a human catastrophe. Data from the 2001 UNAIDS
surveillance report have estimated that 40 million
people are living with HIV/AIDS worldwide.1 Sub-
Saharan Africa has borne the brunt of the epidemic
with South Africa having one of the highest seropre-
valence rates in the world.
Extrapolation of data from the 1999 National HIV
Seroprevalence Survey of women attending public
antenatal clinics in South Africa has shown that
approximately one in ten South Africans are infected
with HIV.2 Poverty, social deprivation and increased
urbanisation among the population appear to be con-
tributory to the spread of the disease. In tandem
with the alarming spread of HIV/AIDS in Africa,
many new and unusual diseases are being discovered
and described for the first time; the field of vascular
surgery being without exception.
Vascular disease due to atherosclerosis is not
uncommon in Africans especially in the elderly as
in the developed world.3 Recently, however, a very
different and bizarre pattern of vascular pathology is
being seen in African patients 20 to 30 years younger
than their western counterparts and often secondary
to HIV infection.
The purpose of this overview is to review the cur-
rent literature including some of our own experiences
and observations on the vascular surgical complica-
tions of HIV/AIDS.
Materials and Methods
Reports and studies for this review were identified by
Pubmed and Medline searches using the keywords:
HIV, acquired immunodeficiency syndrome, aneur-
ysm, vasculitis and occlusive disease. Selection prior-
ity was given to those describing patient series or
individual case studies where vascular surgical inter-
vention was required.
Much of our present experience regarding the vas-
cular surgical complications of AIDS has come from
Southern Africa. In order to complement already pub-
lished papers, several anecdotal reports and unpub-
lished data from this institute are included in this
overview.
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The Spectrum of Vascular Disorders
in HIV/AIDS
Infection by the HIV-1 virus results in diffuse endo-
thelial dysfunction affecting multiple organ systems.
Many of the manifestations of AIDS may be due to
alterations in endothelial function4 (Fig. 1). Increased
endothelial permeability for instance, is believed to
cause serum protein leakage across the blood brain
barrier and enhanced diapedesis of HIV infected
monocytes into the brain contributing to HIV enceph-
alitis.5,6 Vascular disorders including a variety of
angiopathies occur in HIV infected individuals. At
capillary level flow disturbances have been noted,
cellular atypia with abnormal expression of endothe-
lial adhesion proteins such as E-selectin and vascular
cell adhesion molecule (VCAM)-1 have also been
demonstrated in the large vessels of AIDS patients.4,7
It is now becoming evident that many of these form
part of a broad and heterogenous spectrum of vascu-
lopathies affecting small, medium and large sized
vessels. They include the non-specific systemic and
infective vasculitides in addition to angioproliferative
lesions such as Kaposi's sarcoma (KS).4
In 1987, Joshi and co-workers8 first described the
arterial lesions that seemed to form part of a
distinctive arteriopathy in paediatric AIDS patients.
Involvement of small and medium sized arteries was
noted with intimal fibrosis, perivasculitis, fragmenta-
tion of elastic tissue coupled with medial fibrosis and
calcification. Infection as a result of immunodeficiency
was proposed as a possible mechanism. Calabrese and
co-workers9 further characterised systemic vasculitis
occurring in HIV infection. In the 14 patients they
reviewed the pattern of vasculitis affecting small
and medium-sized vessels included a polyarteritis
nodosa-like inflammatory arteriopathy, primary angii-
tis of the central nervous system and the angiocentric
lymphoproliferative disorders. Interestingly, despite
the polymorphic nature of the pathology, the disease
was often confined to a single or small number of
visceral vessels. Target organs usually involved
include the central nervous system, peripheral nerves,
muscle and skin. More recently, several reports from
Durban have described a large vessel HIV-associated
vasculopathy that may play a role in the pathogenesis
of HIV-related aneurysms, occlusive disease and
spontaneous arteriovenous fistulae.10,11
HIV-Related Aneurysms
The existence of an aneurysmal arteriopathy affecting
the Circle of Willis has been well described in paedi-
atric patients with HIV/AIDS.12 Outside the CNS,
initial reports of aneurysmal involvement of large
vessels in these patients were infective in aetiology,
usually occurring secondary to direct infection of the
vessel wall or the sac of a pre-existing atherosclerotic
aneurysm by pathogenic bacteria. However, studies
from Zimbabwe and South Africa have reported
aneurysms occurring as a result of an arteritic process
without an infective aetiology.13±15 Similar pathological
features were noted in patients with large vessel
occlusive disease.10 The frequent observation of
aneurysmal and occlusive disease in large elastic
arteries of patients with HIV/AIDS has prompted
the search to define the nature of what appears to be
an HIV-associated large vessel vasculopathy.
In 1989 Dupont et al.18 described a mycotic abdom-
inal aortic aneurysm secondary to salmonella in a
patient with AIDS. They proposed that the vascular
lesion of AIDS would probably be the scenario of an
abdominal aortic aneurysm infected with salmonella.
Since then there have been several case reports and
small series documenting the association of atypical
aneurysms in HIV infected patients (Table 1). Aneur-
ysmal disease in patients with HIV/AIDS appears to
follow two principal patterns ± those associated with
an identifiable infective organism and those without.
The literature is scattered with reports describing
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Fig. 1. Summary of the effects of the HIV-1 virus on the vascular
endothelium.
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mycotic aneurysms occurring in sero-positive patients
usually as secondary infection of pre-existing athero-
sclerotic aortic aneurysm.18±21 Furthermore, infected
false aneurysms of the femoral artery have been well
described in HIV positive drug addicts.22 Blood-borne
spread or direct inoculation of bacteria into a diseased
or healthy vessel seems a plausible explanation
for such cases. Various organisms have been impli-
cated including Staphylococcus aureus, Mycobacterium
tuberculosis (TB) and Treponema pallidum (syphilis).13,14
Table 1. Reports of HIV-related aneurysms, occlusive disease and primary arterio-venous fistulae.
Author/year Country No. of
patients
Site and No. Aetiology Operation
HIV-related aneurysms
Dupont,18 1989 U.S.A. 1 AAA Salmonella Dacron graft
2 Carotid S. epidermidis 1 PTFE graft
Sinzobahamvya,13 1989 Zimbabwe 1 AAACarotid ? Tuberculous
Mestres,20 1990 Spain 1 AAA Salmonella Dacron graft
Salmonella,
Gouny,9 1992 France 3 AAA H. influenzae 3 Dacron grafts
M. tuberculosis
Thoracic aorta, 2
Marks,14 1995 Zimbabwe 12 Thoracoabdominal, 1
AAA, 1
Iliac, 3
Gluteal, 1
Femoral, 1
Popliteal, 2
Subclavian, 1
? arteritic
Granulomatous
periarteritis
S. aureus
Unsucessful repair
1 repaired
1 repaired
1 ligated
1 RSVG
1 ligated, 1 amputation
1 RSVG
Zell,21 1995 U.S.A. 1 Femoral Salmonella
Nair,15 1999 South Africa 10
Carotid, 8 1 Salmonella, 1 mixed
organisms
3 ligated, 1 Vein graft
Femoral, 6 large vessel vasculitis 2 PTFE grafts, 1 RSVG
1 PTFE tube graft
AAA, 3
Thoracoabdominal, 2
Subclavian, 1
Brachiocephalic, 1
Brachial, 1
Axillary, 1
Popliteal, 1
Superior mesenteric, 1
Coeliac, 1
Piccinato,27 1999 Brazil 2 AAA
Iliac
Necrotising
arteritis
1 Dacron patch
1 Dacron graft
Wild,29 2000 Germany 3 AAA 2 Dacron grafts
1 PTFE (fem-fem)
Wong,17 2002 U.S.A. 1 Subclavian
Lymphoplasmacytic
vasculitis Dacron Graft
Occlusive disease
Bayley,33 1990 Zambia 1 Aorto-iliac Non-surgical
treatment
Marks,14 1995 Zimbabwe 1 Aorto-iliac Fibrogranulomatous
arteritis
Axillo-bifemoral
Dacron graft
Nair,16 2000 South Africa 20
Aorto-iliac, 10
Femoral/popliteal, 12
Tibio-peroneal, 7
Large vessel
vasculitis
1,PTFE, 2 Vein grafts,
1 PTA
4 Embolectomies
8 major amputations,
5 minor amputations
1 lumbar sympathectomy
Primary AV Fistulae
Nair,11 2001 South Africa 1 Femoral Large vessel vasculitis Vein graft
AAA, abdominal aortic aneurysm; PTFE, polytetrafluoroethylene; RSVG, reversed saphenous vein graft;
PTA, percutaneous transluminal angioplasty.
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Chetty and co-workers10 have proposed that non-
mycotic aneurysmal disease occurring in HIV infected
individuals may be due to a large vessel vasculitic
process. The histological features are typically that of
a leucocytoclastic vasculitis of the vasa vasorum with
proliferation of slit like vascular channels within the
adventitia. Weakening of the vessel wall due to the
arteritic process usually results in the formation of
saccular type aneurysms. Rupture is common at an
early stage with the development of pseudoaneur-
ysms. Other workers have described similar findings
in HIV positive patients with atypical aneurysms.17 In
our own practice the features of HIV-associated aneur-
ysms have recently been described as a distinct clin-
icopathological entity.15 The majority of these patients
are young with multiple aneurysms at unusual sites
often affecting the superficial femoral and carotid
arteries. Many have the signs of full-blown AIDS
including oral candidiasis, skin dermatoses, diffuse
lymphadenopathy and weight loss. Furthermore,
advanced states of immunosuppression were con-
firmed by lymphocyte flow cytometry that showed
depressed CD4 counts below normal and inverted
CD4/CD8 ratios.15,23
The coexistence of vasculitic syndromes with the
acquired immunodeficiency syndrome is somewhat
of an epidemiological enigma. Not all HIV infected
patients develop these conditions and therefore with
the lack of controlled epidemiological studies present
knowledge has been derived from clinical observa-
tions alone. From a pathophysiologic perspective,
defining the role played by HIV itself is still further
complicated by the diverse opportunistic infections
that are known to be associated with vasculitic syn-
dromes such as Epstein±Barr virus (EBV), Hepatitis B
(HBV) and Cytomegalovirus (CMV).24
The precise mechanisms by which the virus induces
large vessel vasculopathy and other vasculitides are
unknown. Several theories have been put forward and
deserve consideration. Calabrese9 has proposed that
the inflammatory vasculopathy may occur as a direct
result of endothelial damage by the virus itself or an
immune complex mediated mechanism in a state of
generalised immune dysfunction. Indeed, electron
microscopy has demonstrated the virus and viral par-
ticles within the vessel wall.25 Moreover, the eosino-
philic nature of the lymphocytic infiltrate of the vasa
vasorum could imply a hypersensitivity reaction to
the infective agent.10 Alternatively, as a direct conse-
quence of immunosuppressive fallout, other oppor-
tunistic viral agents such as EBV, HBV or CMV may
be responsible for the vasculitic process. The role of
fastidious organisms that are difficult to isolate by
standard techniques such as Chlamydia pneumonia,
CMV, Herpes simplex and odontopathogens, that are
known to colonise atherosclerotic plaques must also
be borne in mind as a possible role in pathogenesis.26
Currently, there is no evidence for the existence of
such organisms in the vessels of HIV-infected patients
but further work using molecular microbiological
techniques such as the polymerase chain reaction
and 16s RNA assays will be required to answer this
question.
Outside Africa HIV-associated aneurysms are rare.
Piccinato and co-workers27 from Brazil described HIV-
associated pseudoaneurysms in two patients, one
Negroid and the other of mixed race. Babudieri
et al.28 have suggested the possible existence of a racial
factor in the aetiopathogenesis in HIV-associated
aneurysms. In his series of 1564 HIV positive
patients of whom 96.9% were white Europeans, only
one 32-year-old black male patient from Senegal was
observed to have an atypical popliteal aneurysm.
Other than mycotic involvement of atherosclerotic
aneurysms there have been scant reports in the
English literature of HIV associated aneurysms due
to large vessel vasculopathy occurring in white
patients. However, more recently, Wild et al.29 from
Germany reported a series of three young, white,
HIV positive male patients with atypical aortic aneur-
ysms that did not appear to be infective in origin.
Until comparative epidemiological data between dif-
ferent race groups is available the question of a racial
factor if any will remain speculative.
Treatment strategies
During the period from 1994 to 2002, thirty-eight HIV
positive patients with 107 aneurysms have been treated
by the Durban Metropolitan Vascular Service.34 The
management of such patients often raises difficult
moral and ethical questions as to the appropriateness
of surgical intervention. Many of these patients are
young and fit and able to tolerate major surgery. In
one notable case, a 24-year old man, despite having
full-blown AIDS presented on four separate occasions
over a 3-year period undergoing successful repairs to
aneurysms of his right external iliac, superficial fem-
oral, left common carotid and left superficial femoral
arteries. In the absence of signs of advanced immuno-
suppression, and if otherwise asymptomatic such
patients should be treated as sero-negative patients
along conventional lines.
We have adopted the policy of offering symptomatic
patients intervention when the risks of surgery are
favourable with respect to the patient's co-morbid
condition. Investigations should follow standard
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practice with every attempt to exclude mycotic causes
of aneurysm formation. Given the tendency for multi-
plicity, aymptomatic aneurysms should be actively
sought using pan-aortography or helical compu-
terised tomography (CT) scans. Duplex ultrasonogra-
phy may also be used to define carotid and femoral
arterial lesions.30
Studies from our own institute have shown that
many of these aneurysms can be treated effectively
using interposition grafting.15,23 There is no evidence
available to suggest superiority of autologous vein to
prosthetic grafts in this setting. However, we have
favoured the use of PTFE (Goretex, Flagstaff, AZ,
U.S.A.) grafts in the femoral artery when a co-existing
deep vein thrombosis was present in an effort to pre-
serve venous collaterals.
Ligation may be an option for those aneurysms
suspected of being infective in origin. This approach
has been used successfully for those involving the
common carotid artery where neurological deficits
following ligation were surprisingly rare.23
The traditional approach for the management of
seronegative patients with mycotic aneurysms has
been control and ligation of healthy artery, excision
of all infected tissue and arterial reconstruction
through uninfected tissue planes. More recently, the
use of in-situ graft replacement for the treatment of
infected aortic aneurysms has been advocated.31
There have been reports that have described this tech-
nique to treat infected atherosclerotic aortic aneur-
ysms in HIV positive patients although its role in
patients with AIDS has yet to be defined.18,19 The
decision to undertake major surgery in this situation
requires sound clinical judgement with the patient's
overall condition and life expectancy taken into
consideration.
Endovascular therapy may be applicable to the
management of HIV-related aneurysms. Only one
patient in our series with an asymptomatic aneurysm
of the profunda femoris artery was treated successfully
using angiographic coil embolisation.23 The concept
of endoluminal stents to treat HIV-related aneurysms
is attractive given their typical features. However,
there have been no reports in the literature describing
the use of stents to treat such lesions. The financial
constraints of State funded health care in South
Africa and the cost of such devices has curtailed
the use of endovascular techniques and our experi-
ence is very limited. Moreover, many of these
patients present late with large, painful aneurysms of
the superficial femoral or carotid artery and are
more amenable to an open procedure to repair the
vessel and evacuate the large amount of thrombus
and clot.
Occlusive Disease in HIV/AIDS
Patients infected with HIV appear to be at risk from
arterial and venous thrombotic events for a variety of
reasons. Bilateral digital gangrene due to small and
medium sized vessel occlusion due to vasculitis, is not
an uncommon finding in sero-positive patients in our
practice and has also been reported by others.24,32 The
various syndromes that have been described in HIV
patients include necrotising and non-necrotising arter-
itis, polyarteritis nodosa, Henoch±Schonlein purpura
and hypersensitivity vasculitis.4
Bayley hinted at the possible link between HIV
infection and peripheral occlusive disease but the
mechanism remains unclear.33 Indeed, in recent years
we have noticed increasing numbers of young
patients presenting with intermittent claudication,
ischaemic rest pain, ulceration or gangrene. Typically,
these patients have characteristic angiogram findings
of long-segment occlusions, pristine vessels proximally
and poor distal run-off if any. Data available from a
recent audit of Black African patients admitted to the
Vascular unit at King Edward VIII Hospital in Durban
during the period from 1995 to 2001, has shown that of
596 patients treated for aorto-distal occlusive disease,
20.1% (n 120) were less than 45 years old.34 Since
voluntary screening for HIV had been introduced in
1996, only 34 patients in this cohort were confirmed to
be sero- positive. Many patients are unwilling and
refuse serological testing and it is likely that the inci-
dence of HIV in this group may be much higher.
Chetty10 and later Nair16 have proposed that occlu-
sive arterial disease in patients with HIV/AIDS occurs
secondary to the same leucocytoclastic vasculitis of
the vasa vasorum that causes large vessel vasculopa-
thy and HIV aneurysmal disease. Although purely
hypothetical it may be that aneurysmal and occlusive
syndromes are bipolar clinical expressions of the same
pathological process. This is not dissimilar to other
arteritic syndromes such as Takayasu's and BehcËet's
disease, where occlusive and aneurysmal forms of
the disease occur but with identical histopathological
features.
The role of thrombotic and thrombophilic states in
HIV/AIDS cannot be ignored. Thrombotic microan-
giopathy involving the renal glomerular arterioles and
thrombotic thrombocytopenic purpura are established
syndromes occurring in AIDS patients.35 Similarly,
acquired protein S deficiency in addition too elevated
titres of antiphospholipid antibodies have also been
described.36±38 Although several cases have been asso-
ciated with venous thromboembolic events,36 the role
of hypercoagulable states in HIV occlusive disease is
still unclear.
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The mechanism of arterial occlusion is probably
multifactorial, possibly involving an arteritis on the
background of a thrombophilic state. However, it is
likely that whatever other factors are involved they
are not mutually exclusive but are highly interactive
and interdependent.
Vascular Surgical Sepsis in HIV/AIDS
Poor wound healing and post-operative wound break-
down following laparotomy and ano-rectal proce-
dures are well reported in HIV positive patients.39,40
Little is known regarding the potential complications
of vascular procedures particularly those involving
prosthetic grafts. Despite many being profoundly
immunosuppressed with low CD4 counts we have
not observed increased rates of wound or graft com-
plications in these patients compared to their sero-
negative counterparts. Nair23 reported only a single
patient who developed infection of an ileo-femoral
interposition graft following repair of an HIV-related
aneurysm. The patient subsequently died of over-
whelming systemic sepsis. There have been reports
from other surgical specialities that suggest that
patients with HIV/AIDS may be at risk of infection
of prosthetic materials and implants. In Zambia,
Jellis41 noted increased rates of orthopaedic implant
sepsis among HIV positive patients undergoing
internal fixation of fractures. Infection of silicone
implants with Mycobacterium avium have also been
described in AIDS patients following previous cos-
metic surgery.42,43
Although the evidence is largely anecdotal, the
repair of infected aortic aneurysms in HIV patients
using in-situ Dacron graft replacement with antibiotic
cover has proved to be safe and effective certainly in
the short term. Time will tell as to the durability of
what is essentially a palliative procedure, although it
is likely that many patients will succumb to AIDS
before the complications of graft sepsis.
Conclusion
Ten to fifteen years ago HIV and AIDS was of little
clinical interest to vascular surgeons but today there
can be no doubt as to the challenges facing surgeons
and other health care workers in dealing with the
complications of this disease especially in Africa
where resources are severely limited. Much of our
present knowledge concerning the mechanisms of
vascular disorders in AIDS is largely hypothetical
and observational and it may take another decade or
more before we are any closer to understanding the
complex effects the virus has on the vascular endothe-
lium. Hopefully, by then, the Holy Grail of a cure
might be in sight if not in hand.
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